$CHRS News Article - Coherus and Junshi Bioscience
Post# of 55
(Total Views: 227)
Posted On: 04/08/2022 1:50:56 PM
$CHRS News Article - Coherus and Junshi Biosciences Present Results of Phase 3 Study of Toripalimab in First Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma at 2022 AACR Annual Meeting https://marketwirenews.com/news-releases/cohe...20748.html
(0)
(0)Coherus BioSciences Inc. (CHRS) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼